Menu

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

The U.S. Food and Drug Administration (FDA) has issued updated information for facilities and medical professionals handling human cell, tissue, or cellular or tissue-based products (HCT/P) with regard to the COVID-19 pandemic, and now, the COVID-19 vaccines.

The FDA emphasizes that there have been no reported cases of transmission of COVID-19 via human cell, tissue, or cellular, or tissue-based products.

See the update, and links to additional information, here.

ASRM Announcements contain information of interest to members about ASRM and its affiliates, NIH, FDA, WHO, or CDC matters.

ReproductiveFacts.org
is a patient education website of ASRM.
 

RFSubscribe.jpg